LivingGLP1
Study S000742

Effects of Exenatide on Hypothalamic Obesity

ClinicalTrials.gov record

Registration

Registration
NCT01061775
Study type
INTERVENTIONAL
Phase
PHASE1; PHASE2
Masking
NONE
Status
COMPLETED
Enrollment
19
Start
2010-01
Primary completion
2013-07
Lead sponsor
Children's Hospitals and Clinics of Minnesota
Conditions
Hypothalamic Obesity
Interventions
DRUG:Exenatide
Results posted
TRUE
Individual participant data sharing
NO

Registered primary outcomes

  • BMI Change [24 weeks]
  • Waist to Height Ratio (WHtR) [24 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.